| PRIVILEDGE - ALPHA JAPAN (EUR) N CAP SYST. HDG | RVI JAPÓN | 48,871400 | 29/10/2026 | 16,62% | 106,10% | ***** |
| RAIFFEISEN MEGATRENDS ESG EQUITIES (I) VTA | RVI OTROS SECTORES | 198,040000 | 29/10/2026 | 16,62% | · | ND |
| THEAM QUANT - EQUITY US PREMIUM INCOME I EUR CAP | RENT. ABSOLUTA. | 168,850000 | 28/10/2026 | 16,62% | 32,14% | **** |
| UBS MSCI EMU SELECTION INDEX FUND EUR I-A ACC | RV EURO | 2.113,695800 | 29/10/2026 | 16,62% | 62,84% | *** |
| UBS MSCI EMU SELECTION INDEX FUND EUR QX ACC | RV EURO | 1.986,366900 | 29/10/2026 | 16,62% | 62,91% | *** |
| WELLINGTON GLOBAL HEALTH CARE EQUITY FUND SGD D ACC HEDGED | RVI SALUD | 11,141115 | 29/10/2026 | 16,62% | 39,37% | **** |
| BELLEVUE FUNDS (LUX) - BELLEVUE OBESITY SOLUTIONS I2 USD | RVI SALUD | 145,884996 | 29/10/2026 | 16,61% | · | ND |
| JPM EMERGING MARKETS SUSTAINABLE EQUITY A (ACC) EUR | RVI EMERGENTES | 154,870000 | 29/10/2026 | 16,61% | 57,07% | ** |
| LO FUNDS - GLOBAL SYSTEMS CHANGE X1 (USD) M CAP | RVI GLOBAL | 10,371149 | 28/10/2026 | 16,61% | · | ND |
| POLAR CAPITAL BIOTECHNOLOGY R USD CAP | RVI BIOTECNOLOGÍA | 9,586703 | 29/10/2026 | 16,61% | · | ND |
